Genmab — Regulatory Filings 2021

Aug 17, 2021

6-K 1 tmb-20210817x6k.htm 6-K Enhanced HTML document created with Toppan Merrill Bridge 9.11.0.85 Created on: 8/17/2021 07:03:28 PM (UTC) HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF AUGUST 2021

COMMISSION FILE NUMBER 001-38976

Genmab A/S (Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes ◻ No ⌧

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes ◻ No ⌧

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony	​	​
​	GENMAB A/S
​	​	​
​	BY:	/s/ Anthony Pagano
​	​	Name: Anthony Pagano
​	​	Title: Executive Vice President & Chief Financial Officer

DATE: August 17, 2021

EXHIBIT INDEX

O
Exhibit	Description of Exhibit
​	​
99.1	Company Announcement Dated August 17, 2021: Capital Increase in Genmab as a Result of Employee Warrant Exercise